Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma Interventions: Drug: Hydroxychloroquine; Drug: Carfilzomib Injection; Drug: Dexamethasone Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital; Oslo University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials